Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte–colony‐stimulating factor exposure to healthy donors

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|6|1269-1274

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.6, 2015-06, pp. : 1269-1274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte–colony‐stimulating factor

By  

TRANSFUSION, Vol. 39, Iss. 5, 1999-05 ,pp. : 451-456

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte–colony‐stimulating factor

By  

TRANSFUSION, Vol. 39, Iss. 5, 1999-05 ,pp. : 542-543

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilar granulocyte–colony‐stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology‐oncology patients

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 246-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors

By  

TRANSFUSION, Vol. 55, Iss. 12, 2015-12 ,pp. : 2855-2863

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 282-288

Karger

Access to resources Recommend Favorite